English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
European Commission
Russell Boniface
| Sep 13, 2017
Merck's Keytruda wins European approval as bladder cancer treatment
Tabitha Fleming
| Jun 2, 2017
European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Robert Hadley
| Apr 5, 2017
European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Kyle Perrotti
| Mar 17, 2017
European Reference Networks help patients with complex diseases find diagnosis, treatment
Amanda Rupp
| Aug 9, 2016
Keytruda gains EC approval as advanced non-small cell lung cancer treatment
Amanda Rupp
| Jun 8, 2016
Positive CHMP opinion granted for Amgen relapsed multiple myeloma treatment
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Jun 2, 2016
Imbruvica gains approval for treating chronic lymphocytic leukemia
Trending
Patient Daily
| Oct 9, 2025
Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+
Technology/Innovation
Patient Daily News Service
| Oct 9, 2025
Babylon Health collapse raises questions about AI claims across industries
Patient Daily
| Oct 9, 2025
AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+
Regulatory
Patient Daily
| Oct 14, 2025
Mackinac Center raises concerns over federal 340B drug pricing program’s market impact
